Literature DB >> 31070842

Accuracy of breast cancer lesion classification using intravoxel incoherent motion diffusion-weighted imaging is improved by the inclusion of global or local prior knowledge with bayesian methods.

Igor Vidić1, Neil P Jerome2,3, Tone F Bathen2,3, Pål E Goa1,3, Peter T While3.   

Abstract

BACKGROUND: Diffusion-weighted MRI (DWI) has potential to noninvasively characterize breast cancer lesions; models such as intravoxel incoherent motion (IVIM) provide pseudodiffusion parameters that reflect tissue perfusion, but are dependent on the details of acquisition and analysis strategy.
PURPOSE: To examine the effect of fitting algorithms, including conventional least-squares (LSQ) and segmented (SEG) methods as well as Bayesian methods with global shrinkage (BSP) and local spatial (FBM) priors, on the power of IVIM parameters to differentiate benign and malignant breast lesions. STUDY TYPE: Prospective patient study.
SUBJECTS: 61 patients with confirmed breast lesions. FIELD STRENGTH/SEQUENCE: DWI (bipolar SE-EPI, 13 b values) was included in a clinical MR protocol including T2 -weighted and dynamic contrast-enhanced MRI on a 3T scanner. ASSESSMENT: The IVIM model was fitted voxelwise in lesion regions of interest (ROIs), and derived parameters were compared across methods within benign and malignant subgroups (correlation, coefficients of variation). Area under receiver operator characteristic curves (ROC AUCs) were calculated to determine discriminatory power of parameter combinations from all fitting methods. STATISTICAL TESTS: Kruskal-Wallis, Mann-Whitney, Pearson correlation.
RESULTS: All methods provided useful IVIM parameters; D was well-correlated across all methods (r > 0.8), with a wider range for f and D* (0.3-0.7). Fitting methods gave detectable differences in parameters, but all showed increased f and decreased D in malign lesions. D was the most discriminatory single parameter, with LSQ performing least well (AUC 0.83). In general, ROC AUCs were maximized by the inclusion of pseudodiffusion parameters, and by the use of Bayesian methods incorporating prior information (maximum AUC of 0.92 for BSP). DATA
CONCLUSION: DWI performs well at classifying breast lesions, but careful consideration of analysis procedure can improve performance. D is the most discriminatory single parameter, but including pseudodiffusion parameters (f and D*) increases ROC AUC. Bayesian methods outperformed conventional least-squares and segmented fitting methods for breast lesion classification. LEVEL OF EVIDENCE: 3 Technical Efficacy: Stage 2 J. Magn. Reson. Imaging 2019;50:1478-1488.
© 2019 International Society for Magnetic Resonance in Medicine.

Entities:  

Keywords:  Bayesian; breast cancer; classification; diffusion imaging; intravoxel incoherent motion

Mesh:

Year:  2019        PMID: 31070842     DOI: 10.1002/jmri.26772

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  4 in total

1.  Renal Diffusion-Weighted Imaging (DWI) for Apparent Diffusion Coefficient (ADC), Intravoxel Incoherent Motion (IVIM), and Diffusion Tensor Imaging (DTI): Basic Concepts.

Authors:  Neil Peter Jerome; Anna Caroli; Alexandra Ljimani
Journal:  Methods Mol Biol       Date:  2021

2.  Intravoxel incoherent motion diffusion-weighted imaging in the characterization of Alzheimer's disease.

Authors:  Nengzhi Xia; Yanxuan Li; Yingnan Xue; Weikang Li; Zhenhua Zhang; Caiyun Wen; Jiance Li; Qiong Ye
Journal:  Brain Imaging Behav       Date:  2021-09-04       Impact factor: 3.978

Review 3.  Diffusion Breast MRI: Current Standard and Emerging Techniques.

Authors:  Ashley M Mendez; Lauren K Fang; Claire H Meriwether; Summer J Batasin; Stéphane Loubrie; Ana E Rodríguez-Soto; Rebecca A Rakow-Penner
Journal:  Front Oncol       Date:  2022-07-08       Impact factor: 5.738

4.  Discrimination of Breast Cancer from Healthy Breast Tissue Using a Three-component Diffusion-weighted MRI Model.

Authors:  Maren M Sjaastad Andreassen; Ana E Rodríguez-Soto; Rebecca Rakow-Penner; Anders M Dale; Christopher C Conlin; Igor Vidić; Tyler M Seibert; Anne M Wallace; Somaye Zare; Joshua Kuperman; Boya Abudu; Grace S Ahn; Michael Hahn; Neil P Jerome; Agnes Østlie; Tone F Bathen; Haydee Ojeda-Fournier; Pål Erik Goa
Journal:  Clin Cancer Res       Date:  2020-11-04       Impact factor: 12.531

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.